A risk factor analysis of prospective symptomatic haemorrhage in adult patients with cerebral cavernous malformation-Reference-Cited by-同舟云学术

A risk factor analysis of prospective symptomatic haemorrhage in adult patients with cerebral cavernous malformation

Published:2014-03-28 Issue:12 Volume:85 Page:1366-1370
ISSN:0022-3050
Container-title:Journal of Neurology, Neurosurgery & Psychiatry
language:en
Short-container-title:J Neurol Neurosurg Psychiatry

Author:

Jeon Jin Sue^ORCID,Kim Jeong Eun,Chung Young Seob,Oh Sohee,Ahn Jun Hyong,Cho Won-Sang,Son Young-Je,Bang Jae Seung,Kang Hyun-Seung,Sohn Chul-Ho,Oh Chang Wan

Publisher

BMJ

Subject

Psychiatry and Mental health,Neurology (clinical),Surgery

Reference17 articles.

1. Cerebral cavernous malformations: natural history and prognosis after clinical deterioration with or without hemorrhage;Porter;J Neurosurg,1997

2. The natural history of cavernous malformations: a prospective study of 68 patients;Moriarity;Neurosurgery,1999

3. An analysis of the natural history of cavernous angiomas;Del Curling;J Neurosurg,1991

4. An analysis of the natural history of cavernous malformations;Kim;Surg Neurol,1997

5. The natural history of intracranial cavernous malformations;Gross;Neurosurg Focus,2011

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Validation of a Supplementary Grading Scale for Outcomes of Brainstem Cavernous Malformations;Stroke;2024-08

2. Outcomes after surgical and nonsurgical treatment of pediatric cerebral cavernous malformation;Pediatric Investigation;2024-06

3. Identifying potential (re)hemorrhage among sporadic cerebral cavernous malformations using machine learning;Scientific Reports;2024-05-14

4. Association of hemorrhage-to-treatment time with outcomes in patients with brainstem cavernous malformations: a nationwide cohort study;International Journal of Surgery;2024-01-18

5. Bleeding risk evaluation in cerebral cavernous malformation, the role of medications, and hemorrhagic factors: a case-control study;Neurosurgical Focus;2023-10